Cellosaurus DG-75 (CVCL_0244)

Cell line name DG-75
Synonyms DG75; D.G.-75; DG 75
Accession CVCL_0244
Resource Identification Initiative To cite this cell line use: DG-75 (RRID:CVCL_0244)
Comments Part of: COSMIC cell lines project.
Part of: MD Anderson Cell Lines Project.
Characteristics: EBV-negative.
Characteristics: Infected by the DG-75 retrovirus, a replication-competent, murine leukemia-related retrovirus. Constitutively produces the virus.
Doubling time: ~40-50 hours (DSMZ).
Microsatellite instability: Instable (MSI-high) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Derived from sampling site: Pleural effusion.
Disease Burkitt lymphoma (NCIt: C2912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 10Y
Category Cancer cell line
STR profile Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=17254797

CSF1PO10,11,12 (ATCC; Cosmic-CLP)
9,10,12 (DSMZ)
10 (PubMed=17254797)
D13S31711 (ATCC; Cosmic-CLP; DSMZ)
9,11 (PubMed=17254797)
D16S53912 (ATCC)
11,12 (Cosmic-CLP; DSMZ)
11 (PubMed=17254797)
D7S82011.3,12,12.3 (ATCC)
12 (Cosmic-CLP)
11.3,12 (DSMZ)
11,12 (PubMed=17254797)
vWA17,18 (ATCC; PubMed=17254797)
17,18,19 (Cosmic-CLP)
16,17,18 (DSMZ)
Web pages http://tcpaportal.org/mclp/

Dirks W.G., Zaborski M., Jager K., Challier C., Shiota M., Quentmeier H., Drexler H.G.
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Leukemia 10:142-149(1996)

Chapman C.J., Zhou J.X., Gregory C.D., Rickinson A.B., Stevenson F.K.
VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection.
Blood 88:3562-3568(1996)

Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G.
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
Blood 91:1680-1687(1998)

PubMed=9685479; DOI=10.1093/nar/26.16.3651
Hultdin M., Gronlund E., Norrback K.-F., Eriksson-Lindstrom E., Just T., Roos G.
Telomere analysis by fluorescence in situ hybridization and flow cytometry.
Nucleic Acids Res. 26:3651-3656(1998)

PubMed=9770427; DOI=10.1006/viro.1998.9363
Raisch K.P., Kushnaryov V.M., Grossberg S.E., Cashdollar L.W.
Constitutive production of a murine retrovirus in the human B-lymphoblastoid cell line, DG-75.
Virology 250:135-139(1998)

PubMed=12706092; DOI=10.1016/S0042-6822(02)00074-0
Raisch K.P., Pizzato M., Sun H.-Y., Takeuchi Y., Cashdollar L.W., Grossberg S.E.
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75.
Virology 308:83-91(2003)

PubMed=17254797; DOI=10.1016/j.biologicals.2006.10.001
Azari S., Ahmadi N., Tehrani M.J., Shokri F.
Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the National Cell Bank of Iran.
Biologicals 35:195-202(2007)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cell line collections ATCC; CRL-2625
NCBI_Iran; C495
Cell line databases/resources CLDB; cl1051
CGH-DB; 9196-4
Cosmic-CLP; 906838
GDSC; 906838
IGRhCellID; DG75
TOKU-E; 3578
Ontologies BTO; BTO:0003637
CLO; CLO_0002767
EFO; EFO_0002160
MCCL; MCC:0000134
Biological sample resources BioSample; SAMN03471755
BioSample; SAMN03473403
Chemistry resources ChEMBL-Cells; CHEMBL3308527
ChEMBL-Targets; CHEMBL2366199
Gene expression databases GEO; GSM710428
GEO; GSM710444
GEO; GSM827239
GEO; GSM1669731
Polymorphism and mutation databases Cosmic; 906838
Cosmic; 931103
Cosmic; 1086327
Cosmic; 1118471
Cosmic; 1191698
Cosmic; 1588563